Zomepirac sodium salt (Standard)

Overview

Zomepirac sodium salt (Standard) is the analytical standard of Zomepirac sodium salt ( HY-B0890 ). This product is intended for research and analytical applications. Zomepirac sodium salt (McN-2783-21-98) is an orally active prostaglandin synthetase inhibitor. Zomepirac sodium salt blocks prostaglandin synthesis and inhibits Collagen ( HY-P72147 )- or Epinephrine (HY-B0447)-induced platelet aggregation. Zomepirac sodium salt can be used for the research of postoperative pain and osteoarthritis.

Application

Products | Products > Disease Areas > Arthritis | Products > Disease Areas > Postoperative Pain | Products > Disease Areas > Osteoarthritis | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Pain | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Others | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > PGE synthase | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-B0890R
• CAS No.: 64092-48-4
• Molecular Formula: C15H13ClNNaO3
• Molecular Weight: 313.71
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source